Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1978 Jun;75(6):2834–2838. doi: 10.1073/pnas.75.6.2834

Somatic cell origin of teratocarcinomas

Beatrice Mintz 1, Claire Cronmiller 1, R Philip Custer 1
PMCID: PMC392659  PMID: 275854

Abstract

Malignant teratocarcinomas arise from developmentally totipotent normal stem cells. Whether the targets are embryonal somatic cells or germinal cells has long been a matter of controversy. Past experiments on teratocarcinoma induction by ectopic grafting of early rodent embryos or fetal germinal ridges have remained ambiguous because embryos ordinarily soon form germ cells, and parthenogenetic germ cells form “embryos.” In order to interrupt the developmental cycle at its most telling point, day 6 (egg-cylinder stage) mouse embryos of genetically sterile types were grafted; in such grafts, only a terminal residue of totipotent embryonal somatic (“ectoderm”) cells is available, and subsequent germ cell development is severely impaired. One graft series, from S1J/+ matings, comprised 25% S1J/S1J presumptive sterile embryos; these grafts formed tumors containing embryonal carcinoma cells as often (47%) as did control +/+ grafts (41%) on the same genetic background. In another series, from W/+ matings, tumors of the sterile W/W genotype were individually identified by means of a closely linked marker, phosphoglucomutase (PGM, EC 2.7.5.1; Pgm-1 locus), coding for electrophoretic enzyme variants and incorporated into the stock. Four tumors were obtained (out of 16) that had the PGM-1D phenotype diagnostic for W/W, and that also contained embryonal carcinoma cells. Therefore, the malignancy arises here in susceptible somatic embryonal stem cells at the terminal stage of their capacity for totipotency. Other teratocarcinomas—whether induced or spontaneous—of ostensible germ-cell origin by parthenogenesis may also depend upon development of the same somatic target cells before neoplastic conversion can occur. A general model based on these experiments is proposed for all malignancies: Malignant transformation of a particular kind of normal stem cell may be possible only when that stem cell has progressed to the threshold of further differentiation.

Keywords: embryonal carcinoma stem cells, postimplantation mouse embryos, W-mutation, steel-mutation, parthenogenesis

Full text

PDF
2834

Images in this article

2836Image
on p.2836
2837Image
on p.2837

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashley D. J. Origin of teratomas. Cancer. 1973 Aug;32(2):390–394. doi: 10.1002/1097-0142(197308)32:2<390::aid-cncr2820320216>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  2. DIXON F. J., MOORE R. A. Testicular tumors; a clinicopathological study. Cancer. 1953 May;6(3):427–454. doi: 10.1002/1097-0142(195305)6:3<427::aid-cncr2820060302>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  3. Damjanov I., Solter D., Belicza M., Skreb N. Teratomas obtained through extrauterine growth of seven-day mouse embryos. J Natl Cancer Inst. 1971 Mar;46(3):471–passim. [PubMed] [Google Scholar]
  4. Dewey M. J., Martin D. W., Jr, Martin G. R., Mintz B. Mosaic mice with teratocarcinoma-derived mutant cells deficient in hypoxanthine phosphoribosyltransferase. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5564–5568. doi: 10.1073/pnas.74.12.5564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Diwan S. B., Stevens L. C. Development of teratomas from the ectoderm of mouse egg cylinders. J Natl Cancer Inst. 1976 Oct;57(4):937–942. doi: 10.1093/jnci/57.4.937. [DOI] [PubMed] [Google Scholar]
  6. Eppig J. J., Kozak L. P., Eicher E. M., Stevens L. C. Ovarian teratomas in mice are derived from oocytes that have completed the first meiotic division. Nature. 1977 Oct 6;269(5628):517–518. doi: 10.1038/269517a0. [DOI] [PubMed] [Google Scholar]
  7. Hutton J. J., Roderick T. H. Linkage analyses using biochemical variants in mice. 3. Linkage relationships of eleven biochemical markers. Biochem Genet. 1970 Apr;4(2):339–350. doi: 10.1007/BF00485782. [DOI] [PubMed] [Google Scholar]
  8. Illmensee K., Mintz B. Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc Natl Acad Sci U S A. 1976 Feb;73(2):549–553. doi: 10.1073/pnas.73.2.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. KLEINSMITH L. J., PIERCE G. B., Jr MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS. Cancer Res. 1964 Oct;24:1544–1551. [PubMed] [Google Scholar]
  10. Linder D. Gene loss in human teratomas. Proc Natl Acad Sci U S A. 1969 Jul;63(3):699–704. doi: 10.1073/pnas.63.3.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Linder D., Hecht F., McCaw B. K., Campbell J. R. Origin of extragonadal teratomas and endodermal sinus tumours. Nature. 1975 Apr 17;254(5501):597–598. doi: 10.1038/254597a0. [DOI] [PubMed] [Google Scholar]
  12. MINTZ B., RUSSELL E. S. Gene-induced embryological modifications of primordial germ cells in the mouse. J Exp Zool. 1957 Mar;134(2):207–237. doi: 10.1002/jez.1401340202. [DOI] [PubMed] [Google Scholar]
  13. Miner G. D., Wolfe H. G. Phosphoglucomutase isozymes of red cells in Mus musculus: additional polymorphism at PGM-l compared by two electrophoretic systems. Biochem Genet. 1972 Dec;7(3):247–252. doi: 10.1007/BF00484823. [DOI] [PubMed] [Google Scholar]
  14. Mintz B., Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3585–3589. doi: 10.1073/pnas.72.9.3585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. STEVENS L. C. Embryology of testicular teratomas in strain 129 mice. J Natl Cancer Inst. 1959 Dec;23:1249–1295. [PubMed] [Google Scholar]
  16. Stevens L. C. Origin of testicular teratomas from primordial germ cells in mice. J Natl Cancer Inst. 1967 Apr;38(4):549–552. [PubMed] [Google Scholar]
  17. Stevens L. C. The biology of teratomas. Adv Morphog. 1967;6:1–31. doi: 10.1016/b978-1-4831-9953-5.50005-6. [DOI] [PubMed] [Google Scholar]
  18. Stevens L. C. The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos. Dev Biol. 1970 Mar;21(3):364–382. doi: 10.1016/0012-1606(70)90130-2. [DOI] [PubMed] [Google Scholar]
  19. Stevens L. C., Varnum D. S. The development of teratomas from parthenogenetically activated ovarian mouse eggs. Dev Biol. 1974 Apr;37(2):369–380. doi: 10.1016/0012-1606(74)90155-9. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES